Evidence map›Paper›PMID 30034777›Full record

ArticleTherapeutic advances in drug safety2018

Does the 5-HT

Greg Scutt, Andrew Overall, Railton Scott, Bhavik Patel, Lamia Hachoumi, Mark Yeoman, Juliet Wright

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Unmet needs in precision psychiatry.World journal of psychiatry · 2025
    Article
  2. Article
  3. Association betweenWorld journal of psychiatry · 2024
    Article
  4. Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Greg ScuttBrighton and Sussex Centre for Medicines Optimisation, School of Pharmacy and Biomolecular Sciences, University of Brighton, Room 313 Cockcroft Building, Brighton, BN2 4GJ, UK.ORCID https://orcid.org/0000-0001-7124-7543
Andrew OverallCentre for Stress and Age Related Diseases, School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK.
Railton ScottBrighton and Sussex Centre for Medicines Optimization, School of Pharmacy and Biomolecular Sciences, University of Brighton and Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Bhavik PatelCentre for Stress and Age Related Diseases, School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK.
Lamia HachoumiCentre for Stress and Age Related Diseases, School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK.
Mark YeomanCentre for Stress and Age Related Diseases, School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK.
Juliet WrightBrighton and Sussex Medical School, Brighton, UK.
University of Brighton · GBBrighton and Sussex Medical School · GB

Funding

Department of Health PB-PG-0408-16130
6 · The paper itself

Abstract

Major depressive disorder (MDD) in older people is a relatively common, yet hard to treat problem. In this study, we aimed to establish if a single nucleotide polymorphism in the 5-HT

Indexed as

ageingBayesian analysisdepressionpharmacogenomics

Identifiers

PMID30034777
PMCPMC6048630
OpenAlexW2797368319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.